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and 11-dehydro-thromboxane B2 (TXB2) excretion rates were
measured as previously described.4 The study protocol was ap-
proved by the local ethics committee, and patients provided
written informed consent.
The effects of LAGB surgery were assessed using Fried-
man and Wilcoxon tests for paired samples. The Spearman rank
correlation test and stepwise multiple linear regression analy-
sis (using log-transformed data) were performed to assess
variables associated with urinary 11-dehydro-TXB2 excretion
rates. Two-sided P values of less than .05 were considered to
be statistically significant.
Results | The clinical and laboratory characteristics of the par-
ticipants are shown in the Table. Lipid peroxidation (8-iso-
PGF2α) and platelet activation (11-dehydro-TXB2), as well as C-
reactive protein levels, progressively decrease at any time point
following LAGB, with significant correlation among the 3 vari-
ables (P = .001). By pooling data from each time point after
LAGB, we found that changes in urinary 8-iso-PGF2α and 11-
dehydro-TXB2 excretion were significantly correlated (ρ = 0.67,
P < .001). Moreover, both changes were significantly related
to the amount of weight lost and to changes in body mass in-
dex, waist circumference, fasting plasma glucose level, and
high-density lipoprotein cholesterol level. Changes in the ho-
meostatic model assessment of insulin resistance (HOMA-IR)
index correlated with changes in 11-dehydro-TXB2 (ρ = 0.466,
P = .02).
A multiple regression analysis of pooled data from base-
line and 6 and 12 months after LAGB indicates that only the
8-iso-PGF2α excretion rate (β = 0.611, t = 6.03, P < .001) and the
HOMA-IR index (β = 0.385, t = 3.81, P = .001) can predict the
rate of 11-dehydro-TXB2 excretion, independent of body
mass index, waist circumference, serum lipid levels, fasting
plasma glucose levels, postprandial plasma glucose levels,
fat mass, and C-reactive protein levels (adjusted R2 = 0.665,
P = .001).
Discussion | We previously identified a novel mechanism
through which obesity may affect cardiovascular morbidity and
mortality (namely, thromboxane-dependent platelet
activation).5 Moreover, we established that isoprostanes may
be a link between obesity and platelet activation. Notably, a
10% reduction in body weight, obtained through a successful
diet-induced weight loss program, was associated with more
than a 50% reduction in thromboxane biosynthesis.4
In our study, the rates of 8-iso-PGF2α and 11-dehydro-
TXB2 excretion were significantly reduced 12 months after
LAGB (by approximately 45% and approximately 60%, respec-
tively), correlated with an approximately 18% decrease in body
weight and with a concomitant decrease (30%) in the level
of C-reactive protein, a marker of systemic inflammation. How-
ever, because severe obesity is characterized by a very high rate
of thromboxane biosynthesis, all but 4 values of thrombox-
ane metabolite excretion did not return to the normal range
12 months after LAGB.
Moreover, weight loss following the surgical procedure sig-
nificantly affected the fasting plasma glucose level, the post-
prandial plasma glucose level, and insulin sensitivity in our
obese participants. Thus, the HOMA-IR index and the 8-iso-
PGF2α excretion rate were the only predictors of the rate of
thromboxane biosynthesis.
In conclusion, LAGB ameliorates the vicious cycle of in-
flammation, oxidative stress, and thromboxane-dependent
platelet activation in obesity. However, the incomplete nor-
malization of thromboxane biosynthesis in the majority of the
obese participants may support the concept that different ge-
notypic/phenotypic subtypes of obesity may exist.
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ASSOCIATION OF VA SURGEONS
Ultrasonography-Guided Identification
With Methylene Blue Tattooing
of the Ilioinguinal Nerve for Neurectomy
for Chronic Pain: A Case Series
Chronic ilioinguinal pain is a common but morbid complica-
tion of inguinal herniorrhaphy for 12% to 62% of patients.1
Although pharmacologic options exist (such as nerve
blocks), long-term pain relief is inferior to surgical
neurectomy.2,3 We present our experience in ilioinguinal
neurectomy with preoperative ultrasonography-guided
identification and perineural injection of methylene blue to
tattoo the nerve.
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Methods | Four patients with inguinodynia who responded fa-
vorably to nerve blocks were referred for neurectomy. Three
patients had pain from herniorrhaphy, and 1 patient had neu-
ropathic pain. Before inducing anesthesia, a staff anesthesi-
ologist localized the proximal nerve using ultrasonography
above the anterior superior iliac spine, anterior to the midax-
illary line, between the transversus abdominis and internal
oblique muscle planes. A 21-gauge nerve stimulator needle re-
produced preoperative pain. The intramuscular plane was hy-
drodissected with 0.5 to 5 mL of normal saline, followed by peri-
neural tattooing with 0.3 to 0.5 mL of methylene blue and 2 to
5 mL of bupivacaine hydrochloride, 0.5%. The skin was marked
to triangulate approximate nerve position. Under general an-
esthesia, a 3-cm transverse incision was made, and the exter-
nal and internal oblique muscles were split in the direction of
the fibers, allowing exposure of the transversus abdominis with
self-retaining retractors. Within the blue-stained fibers of the
transversus abdominis, we identified and dissected out the il-
ioinguinal nerve (Figure). The nerve was ligated proximally and
distally, and a segment was sent for frozen section. All pa-
tients were discharged home without complications and were
followed up for 4 weeks after surgery.
Results | During surgery, the nerve was positively identified in
all patients. The time from incision to localization was as short
as 7 minutes. At follow-up, all patients had expected numb-
ness over the distribution of the nerve. Three of the 4 pa-
tients experienced complete or near-complete resolution of
pain, although 1 of the 3 patients had incisional hyperesthe-
sia. The fourth patient experienced numbness but no pain re-
lief. However, this patient’s pain was eventually relieved by the
excision of an inguinal lymph node.
Discussion | Ilioinguinal neurectomy is effective at reducing pain
after inguinal herniorraphy.4 Traditionally, surgeons have re-
lied on anatomic landmarks in the postoperative groin; suc-
cess depends on finding the nerve within scarred and obliter-
ated tissue planes. Dissection may be arduous, may damage
surrounding structures, or may require mesh removal.5 Using
stimulator needle localization with directed cutdown can im-
prove detection, but this advantage is lost if the needle slips.
These problems necessitated a more reproducible, efficient
technique that permits the quick identification of the nerve
without the aforementioned pitfalls.
Our technique is based on the transversus abdominis plane
block, which is used in our facility for postoperative analgesia.6
A strong ultrasonographic experience is critical to identifying
the nerve within the muscle but can be time-consuming. After
confirmation of the nerve by stimulation, minimizing dye injec-
tion prevents tattooing too wide an area. Localization allows for
a small, roughly 3-cm incision far from previous scar tissue, and
dissection is similar to the Rocky-Davis approach to appendec-
tomy. Within the transversus abdominis fibers, the nerve will
be visible against blue-stained muscle, allowing for easier liga-
tion and division. None of our patients required removal of mesh.
The time required for identification of the nerve varies based on
the learning curve and the depth of the subcutaneous tissues,
and good retraction is critical for visualization. Overall, this pro-
cedure reduces morbidity while allowing the surgeon to more
quickly and easily treat the patient’s inguinodynia.
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ASSOCIATION OF VA SURGEONS
Decreased Wait Times After Institution
of Office-Based Hand Surgery in a Veterans
Administration Setting
Carpal tunnel syndrome is a common peripheral nerve com-
pression disorder causing symptoms of numbness, tingling,
weakness, and muscle atrophy. Open carpal tunnel release
(CTR) is a common treatment modality traditionally per-
formed in the operating room with sedation or general anes-
thesia. It can also be performed in the surgeon’s office under
local anesthesia only.1 In our study, we examined the number
of days from initial consultation and visit to operative inter-
vention in a Veterans Administration (VA) setting. A signifi-
cant decrease in wait time from initial consultation to opera-
tive intervention and from initial visit to operative
intervention was hypothesized to occur with the transition
to office-based hand surgery procedures, without an
increase in complications.
Methods | Institutional review board approval from the Richard
L. Roudebush VA Medical Center was obtained to construct a
database of recent surgical procedures performed for carpal
tunnel syndrome by the plastic surgery service. Operations in-
cluding CTR in conjunction with other procedures were ex-
cluded. The minor procedure room is located within the plas-
tic surgery clinic, with a single nurse serving as a circulating
nurse. The hand and forearm are prepped and draped, and both
monopolar cautery and bipolar cautery are available. A more
specific description to a similar configuration can be found in
Leblanc et al.2 The study variables collected were age, sex, to-
bacco use, procedure, time from initial consultation to sur-
gery (in days), time from initial clinic visit to surgery (in days),
location of the procedure (the minor procedure room in the
surgeon’s office or the operating room), and complications. An
independent 2-tailed t test was used to compare mean values
using SPSS version 20 (IBM).
Results | Two separate types of CTR were analyzed: office-
based CTR (44 patients) and operating room–based CTR (54
patients). The Table contains a comparison of the 2 groups
of patients who underwent 1 of the 2 types of CTR. Signifi-
cant decreases in time from initial consultation to surgery
and from initial clinic visit to surgery were observed in the
office-based group (P < .05). There was no difference in
complications between the 2 groups. Complications in the
operating room–based group included 2 infections requiring
oral antibiotics and 4 minor wound dehiscences that
resolved with local wound care. In the office-based group,
there were 2 infections (one requiring intravenous antibiot-
ics and the other resolving with oral antibiotics) and 2 minor
wound dehiscences.
Discussion | Office-based hand surgery procedures have been vali-
dated in a variety of settings but are not the default method of
performing hand surgery procedures in the United States. We
have demonstrated a significant decrease in time to procedure
with the use of an office-based procedure in a VA setting, with-
out sacrificing quality. Open CTR can be completed safely in the
office; the complication rate was not statistically different be-
tween the 2 groups in our series. To our knowledge, this is the
first description of decreased times to surgery due to the insti-
tution of office-based open CTR. Previous studies demonstrated
that early intervention is associated with a faster return to daily
activities of living and to normal function compared with late
intervention.3 The limitations of our study include its retrospec-
tive nature and the steps of conservative management, includ-
ing steroid injections, which are often offered to patients who do
not wish to undergo surgery immediately. A wider application
of office-based minor hand surgery would likely result in signifi-
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Table. Demographic and Wait-Time Data
Data








Age, mean (SD), y 59.5 (11.9) 59.0 (12.2) .84
Smoking status, No. (%)
Current 17 (31.5) 12 (27.3)
Former 13 (24.1) 6 (13.6)
Never 23 (42.6) 24 (54.5)
Unknown 1 (1.9) 2 (4.5)
Female sex, No. (%) 5 (9.3) 4 (9.1) .97
Time, mean (SD), d
From initial visit to
surgery
247.5 (178.2) 122.5 (139.4) .05
From consultation to
surgery
310.7 (168.7) 233.7 (154.3) .05
Experienced complications,
No. (%)
6 (11.1) 4 (9.1) .75
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